Paper20409751
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I and 4 others. Lancet Oncol, 2010. Cited by 1,390 papers, by iCite.
Cite this record
ConductScience Library. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Papers, record 20409751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20409751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Lymph Node Excision | Major topic |
| Stomach Neoplasms | Major topic |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Gastrectomy | |
| Humans | |
| Male | |
| Prospective Studies | |
| Survival Analysis |
Source PubMed
Trials6
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01476553 | Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer | Background | ClinicalTrials.gov | |
| NCT01609309 | Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) | Background | ClinicalTrials.gov | |
| NCT03229096 | Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer | Background | ClinicalTrials.gov | |
| NCT03680261 | Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy | Background | ClinicalTrials.gov | |
| NCT04734821 | Fluorescence Image Guided Foregut Surgery | Background | ClinicalTrials.gov | |
| NCT06466902 | Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes) | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 20409753 | Extended follow-up after extended lymphadenectomy for gastric cancer: was it worth the wait? | https://conductscience.org/library/papers/20409753 |
Source PubMed
Cited by846
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,390 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42970017 | [Minimally invasive and robotic gastrectomy]. | Chirurgie (Heidelb) | 2026 | https://conductscience.org/library/papers/42970017 | PubMed |
| 42959646 | Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42959646 | PubMed |
| 42934447 | Extent of Lymph Node Examination in Older Adults with Gastric Adenocarcinoma: Is There a Trade-off Between Survival and Short-Term Outcomes? : Benefit of Lymph Node Yield in Older Adults with Gastric Cancer. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42934447 | PubMed |
| 42846330 | Re-evaluation of lymph node dissection and surgical strategy for locally advanced gastric cancer in the era of neoadjuvant immunotherapy: a narrative review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42846330 | PubMed |
| 42820568 | Fluorescence-guided lymphadenectomy in gastric cancer surgery: a novel intraoperative indocyanine green injection. | Arq Bras Cir Dig | 2026 | https://conductscience.org/library/papers/42820568 | PubMed |
| 42809545 | Prognostic impact of postoperative complications among elderly patients with gastric cancer. | PLoS One | 2026 | https://conductscience.org/library/papers/42809545 | PubMed |
| 42807388 | Glycolytic Reprogramming Mediated by the OTUD4-FXR1-HIF1A Axis Drives Gastric Cancer Progression. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42807388 | PubMed |
| 42742771 | Complexity and heterogeneity of vascular anatomy in gastric cancer surgery: a multicenter retrospective cohort study. | J Robot Surg | 2026 | https://conductscience.org/library/papers/42742771 | PubMed |
| 42690309 | Clinicopathological features, morbidity and survival in gastric adenocarcinoma, with a focus on stage III: a retrospective institutional cohort analysis. | Arq Bras Cir Dig | 2026 | https://conductscience.org/library/papers/42690309 | PubMed |
| 42682346 | Operative safety and oncologic outcomes of robotic and laparoscopic total gastrectomy for advanced middle-upper gastric cancer: a multicenter retrospective study. | Int J Surg | 2026 | https://conductscience.org/library/papers/42682346 | PubMed |
| 42665277 | Diagnostic performance of Node-RADS in assessing regional lymph node metastasis and prognosis in resected gastric cancer. | Sci Prog | 2026 | https://conductscience.org/library/papers/42665277 | PubMed |
| 42632878 | Impact of Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) on Survival Following Surgery for Esophagogastric Cancer: A Systematic Review and Meta-analysis. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42632878 | PubMed |
| 42514138 | Comparative Effectiveness of Adjuvant XELOX Versus TS-1 Monotherapy After D2 Gastrectomy for Stage III Gastric Cancer: A Real-World Nationwide Cohort Study. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42514138 | PubMed |
| 42482917 | Mechanobiological and microenvironmental roles of lymph nodes in cancer: implications for lymph node de-escalation. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42482917 | PubMed |
| 42448965 | Non-exposure LECS (CLEAN-NET) for gastric cancer: long-term outcomes of a function-preserving strategy with selective nodal assessment. | Surg Endosc | 2026 | https://conductscience.org/library/papers/42448965 | PubMed |
| 42352420 | Current Status and Challenges of Local Resection for Early Gastric Cancer in East Asia. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42352420 | PubMed |
| 42077699 | Clinicopathological Characteristics and Survival Outcomes in Patients With Gastric Adenocarcinoma: A 16-Year Experience From a Single Tertiary Center in Tunisia. | Cureus | 2026 | https://conductscience.org/library/papers/42077699 | PubMed |
| 41999560 | Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery. | J Gastrointest Cancer | 2026 | https://conductscience.org/library/papers/41999560 | PubMed |
| 41959925 | Differences in patient-reported symptoms following radical gastrectomy: a propensity score-matched cohort study. | Front Oncol | 2026 | https://conductscience.org/library/papers/41959925 | PubMed |
| 41879959 | Limited lymphadenectomy for elderly patient with gastric cancer: a systematic review and meta-analysis. | Gastric Cancer | 2026 | https://conductscience.org/library/papers/41879959 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20409751
GET https://conductscience.org/api/papers/v1/20409751/cited_by?page=2